Company Filing History:
Years Active: 2023-2025
Title: Innovations by Inventor Alan H. Cherney
Introduction
Alan H. Cherney, an accomplished inventor based in Somerville, Massachusetts, has made significant contributions to the field of pharmaceuticals. With a total of two patents, he has focused on innovative compounds that address medical needs, particularly in the realm of pain management and related disorders.
Latest Patents
Alan's latest patents include groundbreaking inventions related to cyclobutyl and cyclopropyl dihydroquinoline sulfonamide compounds. The first patent, concerning cyclobutyl dihydroquinoline sulfonamide compounds, offers compounds that inhibit voltage-gated sodium channels, specifically Nav1.7. These compounds have the potential to be utilized in treating various diseases linked to sodium channel activity, including pain disorders, cough, and itch. The patent also details pharmaceutical compositions containing these compounds, along with methods for their atropi-selective preparation.
The second patent focuses on cyclopropyl dihydroquinoline sulfonamide compounds, which further exemplifies Alan’s commitment to developing innovative solutions for pressing health challenges.
Career Highlights
Alan H. Cherney is affiliated with Amgen Inc., a leading biotechnology company dedicated to discovering, developing, and delivering innovative human therapeutics. His work at Amgen highlights his expertise in advancing pharmaceutical research through his inventive capabilities.
Collaborations
Throughout his career, Alan has likely collaborated with diverse teams in research and development, contributing to cross-functional projects aimed at pioneering medical products that can significantly enhance patient care and quality of life.
Conclusion
Alan H. Cherney stands out as a key innovator in the pharmaceutical industry. His contributions through patents reflect his dedication to addressing critical health issues. As the field of medicine continues to evolve, his inventions promise to pave the way for effective treatments and improve healthcare outcomes.